Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Newsletter Article
|
US Patent Issued to VigNet on Feb. 13 for "Using genetic and phenotypic data sets for drug discovery clinical trials" (Virginia, Oregon Inventors)US Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Feb 14, 2024Digital Resources/Online E-Resources |
|
2 |
Material Type: Newsletter Article
|
Using Genetic and Phenotypic Data Sets for Drug Discovery Clinical TrialsTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
3 |
Material Type: Newsletter Article
|
The never-ending debate: are sweeteners bad for health or not?CE Noticias Financieras, 2023CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
4 |
Material Type: Newsletter Article
|
Are sweeteners harmful to health?CE Noticias Financieras, 2023CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
5 |
Material Type: Newsletter Article
|
Cofepris approves Phase 3 of German CureVac vaccineCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
6 |
Material Type: Newsletter Article
|
Russia begins process for Sputnik V clinical trials in MexicoCE Noticias Financieras, 2020CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
7 |
Material Type: Newsletter Article
|
Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder: Findings underscore the liver safety of AD04 as compared to placebo in the prior Phase 3 clinical trialNASDAQ OMX's News Release Distribution Channel, 2024GlobeNewswire, Inc.Digital Resources/Online E-Resources |
|
8 |
Material Type: Newsletter Article
|
Press Release: Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use DisorderDow Jones Institutional News, 2024Copyright Dow Jones & Company Inc. Apr 10, 2024Digital Resources/Online E-Resources |
|
9 |
Material Type: Newsletter Article
|
Patria Vaccine: Will it take a year to apply?CE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
10 |
Material Type: Newsletter Article
|
Patria Vaccine: implementation will take a year to be finalizedCE Noticias Financieras, 2024CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
11 |
Material Type: Newsletter Article
|
Physicians Group to SEC: Elon Musk's DealBook Summit Claims About Dead Monkeys May Be Securities FraudTargeted News Service, 2023Targeted News ServiceDigital Resources/Online E-Resources |
|
12 |
Material Type: Newsletter Article
|
Bootleg Obesity Drug Sold Online -- WSJDow Jones Institutional News, 2023Copyright Dow Jones & Company Inc. Oct 21, 2023Digital Resources/Online E-Resources |
|
13 |
Material Type: Newsletter Article
|
Cofepris authorizes 20 new drugs and 103 medical devices in the last 15 daysCE Noticias Financieras, 2023CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
14 |
Material Type: Newsletter Article
|
FSRH Response to New Study Using Mathematical Model to Inform Dose, Regimen of Exogenous HormonesTargeted News Service, 2023Targeted News ServiceDigital Resources/Online E-Resources |
|
15 |
Material Type: Newsletter Article
|
University of Oklahoma: TSET Health Promotion Center Expands Research Mission With Focus on ObesityTargeted News Service, 2024Targeted News ServiceDigital Resources/Online E-Resources |
|
16 |
Material Type: Newsletter Article
|
Ebrard points out that Mexico will begin phase 3 of CureVac and Novavax Covid-19 vaccinesCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
17 |
Material Type: Newsletter Article
|
Physicians Group Asks SEC to Investigate Elon Musk for Securities Fraud Stemming From False Statements About Neuralink Monkey DeathsTargeted News Service, 2023Targeted News ServiceDigital Resources/Online E-Resources |
|
18 |
Material Type: Newsletter Article
|
TSET HEALTH PROMOTION CENTER EXPANDS RESEARCH MISSION WITH FOCUS ON OBESITYUS Fed News Service, Including US State News, 2024Copyright HT Digital Streams Limited Jan 25, 2024Digital Resources/Online E-Resources |
|
19 |
Material Type: Newsletter Article
|
Russian embassy celebrated approval of Sputnik V vaccine in MexicoCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |
|
20 |
Material Type: Newsletter Article
|
SPUTNIK V, BARATA AND UNEFI EFFECTIVE VACUNA acquired by CAPRICHO from AMLOCE Noticias Financieras, 2021CE Noticias Financieras English, Latin America - Distributed by ContentEngine LLCDigital Resources/Online E-Resources |